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Lead is a widely spread environmental pollutant known to aﬀect both male and female reproductive systems in humans and
experimentalanimalsandcausesinfertilityandotheradverseeﬀects.Thepresentpaperinvestigatedtheeﬀectsofprenatalexposure
to lead on diﬀerent parameters of estrogen stimulation in the uterus of the prepubertal rat. In prenatally and perinatally exposed
rats,estrogen-inducedendometrialeosinophilia,endometrialstromaedema,andeosinophilmigrationtowardstheendometrium,
anduterineluminalepithelialhypertrophyareenhancedwhileseveralotherresponsestoestrogenappearunchanged.Theseeﬀects
may contribute to decrease in fertility following prenatal exposure to lead. The striking diﬀerence between most of these eﬀects
of prenatal exposure and the previously reported eﬀects of chronic exposure to lead suggests that prenatal exposure to lead may
neutralize the eﬀects of chronic exposure to lead, providing partial protection of cell function against the adverse eﬀects of chronic
exposure to lead. We propose that the mechanism involved, named imprinting or cell programming, persisted through evolution
as a nongenetic adaptive mechanism to provide protection against long-term environmental variations that otherwise may cause
the extinction of species not displaying this kind of adaptation.
1.Introduction
Infertility and other reproductive alterations may be caused
by a myriad of environmental toxic agents, among them
lead. This toxic environmental pollutant is widely spread and
aﬀectsbothmaleandfemalereproductivesystemsinhumans
[1] and in experimental animals [2]. The most known
eﬀects reported in women include infertility, increase in
time needed to achieve pregnancy, miscarriage, preeclamp-
sia, pregnancy hypertension, premature delivery [1, 3, 4],
polymenorrhea, prolonged and abnormal menstruations,
hypermenorrhea, and important increase in the incidence
of spontaneous abortions [5]. In fact, as early as in 1965,
Gilﬁllan [6] suggested that the declining birth rate in Rome’s
ruling class, which may have been at the root of the empire’s
dissolution, was a result of exposure to lead in food and
wine. In experimental animals, chronic exposure to lead
may cause an inhibition of menstruation, ovulation, and
follicular growth in monkeys [7], a delay in vaginal opening
in pubertal rats [8], and a decrease in frequencyof implanted
ova and of pregnancies in mice [9].
Several mechanisms may be involved in the alteration
of fertility by lead, which were mainly investigated in ex-
perimental animals. Among them, changes may occur at the
enzyme levels [10, 11] or in the action of sex steroid hor-
mones themselves, mainly estrogens, in the uterus [12–14].
The interaction of lead with hormone action may be direct,
via qualitative or quantitative changes in hormone receptors
[15], or caused by changes in levels of other hormones that
modify the action of sex steroids, such as glucocorticoids
[16]a n dp r o l a c t i n[ 17], hormones that increase under the
eﬀect of exposure to lead [18]. Further, in agreement with
the existence of independent mechanisms of estrogen action
in the uterus that are involved in the generation of separate
groups of responses to hormone stimulation, and the report
of diﬀerences in the regulation of estrogen action in each
uterine cell-type [16, 19–23], it was reported that exposure
to lead dissociates responses to estrogen in the uterus: it2 ISRN Obstetrics and Gynecology
selectively enhances some of these responses, inhibits others
while a third group remains unaﬀected [12–14].
The heterogeneity of biochemical processes related to
fertility that are aﬀected by lead, together with the existence
of multiple and independent mechanisms of estrogen action
[16, 19–21, 24, 25], provides an explanation for a report of
time-dependent diﬀerences between the diﬀerent eﬀects of
lead on reproductive changes [11]. In fact, we previously
reported selective changes in some parameters of estrogen
action following acute [13], subacute [12], or chronic [14]
exposure to lead of prepubertal rats, which can be addi-
tionally explained in part by hematologic changes caused by
lead [26] which, in turn, aﬀect estrogen action in the uterus
[16, 21, 27, 28].
Besides chronic exposure to lead, prenatal and perinatal
exposure to the pollutant is one of the most common con-
ditions aﬀecting human population. Since the ﬁrst reports
linking the development of clear cell cervicovaginal adeno-
carcinoma in young women with diethylstilbestrol treatment
of their mothers during pregnancy [29], it became clear
that prenatal or neonatal exposure to several substances may
additionally generate irreversible morphological, biochem-
ical, and functional alterations that can be detected later
in life. This process was named imprinting, and the ﬁrst
group of substances reported to cause this kind of alterations
is comprised by hormones and xenobiotics displaying hor-
monal action [30–32]. It was suggested that the mechanism
of imprinting is a modiﬁcation in the path of diﬀerentiation
of the aﬀected cell types [33], which can be detected in these
cells as late as in adulthood as irreversible quantitative and
qualitative changes in hormone receptors or responses to
hormone stimulation mediated by them [32, 34]. Based on
the above mechanism, a new name was proposed for it: “cell
programming (or reprogramming) process” [35, 36]. We
suggestedthatthesechanges,whichpersistthroughlife,facil-
itatethedevelopmentofvariousdiseasesduringtheadultage
[36–38]. Subsequent studies lead to the ﬁnding that not only
hormones, but additionally several pharmaceutical agents,
pollutants, stress, food additives, some natural components
of food, and several substances present in plants, display the
ability to induce imprinting [33, 35–44].
Although few studies investigated the eﬀects of prenatal
exposuretolead,severaldelayedeﬀectswerealreadyreported
in brain, ovary, and uterus. In the rat brain, prenatal expo-
sure to lead was found to cause a permanent increase in
the aﬃnity of δ-[ 45]a n dμ-opioid, but not κ-opioid re-
ceptors [46], that parallels the impairment of opioid but
not nonopioid stress-induced antinociception in developing
rats [47]. In the ovary, perinatal exposure to lead was
reported to cause a persistent change in LH receptors and
in steroidogenesis [10], and in the uterus, lead was found to
induce persistent changes in number and aﬃnity of uterine
estrogen receptors [48].
The report of delayed eﬀects caused by prenatal exposure
to lead at uterine estrogen receptor level suggests the possibi-
lity that exposure may cause persistent alterations in the
action of the hormone in the uterus. The present study des-
cribes the eﬀect of prenatal exposure to lead on estrogen
action in prepubertal rat uterus, and compares these eﬀects
to those previously reported following chronic exposure to
the pollutant. Additionally, the present study investigated
the possible hematologic changes in rats prenatally exposed
to lead, taking into consideration the role of eosinophil
leukocytes in estrogen action [21].
The experimental conditions in the present study are
intended to investigate, in an animal model, conditions freq-
uently occurring in the human species: pregnant women
displaying high lead blood levels as a cause of their child’s
prenatal exposure to lead; subsequent breast feeding as the
source of the continuation of exposure after birth.
2.MaterialsandMethods
Female rats from a Sprague-Dawley-derived colony bred
at the vivarium of the Faculty of Medicine, University of
Chile, were used in the present study. Four groups of
female pregnant animals were subjected to the following
procedure. The animals received a single dose of lead acetate
(Merck, Darmstadt, Germany) of 235μgPb ++ g−1 body wt
s.c. (total lead dose averaged 61mgPb++ per animal) or
saline physiological solution, at the 14th day of pregnancy
(the day when spermatozoa were found in the vaginal smear
was considered as the ﬁrst day of pregnancy). From some
lead exposed pregnant rats not included in the study of their
oﬀspring, blood samples were takenat24, 48 72, 96, 120, and
168h after lead injection, for measurement of their blood
lead levels. Blood was also obtained from some nonexposed
pregnant rats not included in the study of their oﬀspring.
The female oﬀspring were allowed to be nursed by their
exposed or nonexposed mothers up to day 21 of life, when
they were treated with estradiol-17β (Sigma Chemical Co.,
St. Louis, MO, USA; 300ngg−1 bodywts.c.) or its vehicle
(absolute ethanol in saline physiological solution 1:9). The
age of 21 days is the most appropriate for the study of the
eﬀects of sex steroids on target organs, since estrogen and
progesterone levels are extremely low and receptor levels and
hormone responsiveness are already fully developed [16]. Six
or 24h after treatment the uteri were excised under ether
anesthesia, and blood samples were taken from the tail of
each animal. The blood was collected into tubes containing
EDTA; two samples were obtained from each animal, one
was used immediately after sample collection for blood cell
quantiﬁcation, the other one was kept at 4◦Cf o rs u b s e q u e n t
lead concentration determination.
T h el e f tu t e r i n eh o r nw a sﬁ x e di n4 %n e u t r a lf o r -
malin and subjected to further histological procedure for
eosinophil quantiﬁcation and morphometric evaluation.
Paraﬃn sections were stained with hematoxylin-eosin as
previously described [25].
Blood collected in EDTA containing tubes was used im-
mediately after sample collection for blood cell quantiﬁca-
tion. Eosinophil quantiﬁcation and evaluation of eosinophil
degranulation [28] was performed in Neubauer cham-
bers following dilution 1:10 with freshly prepared eosin
stain solution (0.5mL of 2% eosin Y stock solution in
100% ethanol diluted in 9mL of distilled water and
0.5mL of acetone). Blood leukocytes were quantiﬁed in a
Neubauer camera diluting an aliquot of blood in HayemISRN Obstetrics and Gynecology 3
B (0.5‰ of a saturated methylene blue solution (Merck,
Darmstadt, Germany) in 3% acetic acid in distilled water)
within 5min of blood sample collection. Blood smears
were ﬁxed in methanol for 10min and stained with May
Grunwald-Giemsa (Merck, Darmstadt, Germany) for the
quantiﬁcation of blood leukocyte diﬀerential counts. Abso-
lute counts were calculated with the information obtained
from blood smears and Neubauer camera counts.
Blood lead concentration was measured in a group of
pregnant rats nonexposed to lead (control without lead) and
in another group of pregnant rats at various times after
lead injection; blood lead levels were also determined in
nonestrogen-treated oﬀspring from saline or lead exposed
animals,usingatomicabsorption spectroscopywithgraphite
furnace at the Chilean Institute of Public Health, Ministry of
Health.
The following parameters of estrogen stimulation were
investigated in the uterus: myometrial hypertrophy was
measured as increase in the reciprocal value of cell density
(RVCD) in circular myometrium; edema in deep endome-
t r i a ls t r o m aw a se v a l u a t e da si n c r e a s ei nR V C Di nt h i s
histological location [49, 50]. Uterine eosinophilia was mea-
sured as total number of eosinophils located in the uterine
horns [27] and as number of eosinophils located in each
uterinehistologicallayer.Luminalepithelialhypertrophywas
evaluated as changes in cell volume [51]; measurements were
performed in at least 48 cell images per animal, at locations
chosen at random in the most central part of luminal
epithelium for luminal epithelial cells. The cell images were
obtained in a Nikon epiﬂuorescence microscope by a cooled
digital camera World Precision Instruments. The resulting
images were processed by computer-assisted image analysis.
2.1. Statistics. Data analysis by the Tukey additivity test sug-
gested that data on uterine eosinophils and blood lead levels
should be subjected to a square root transformation to
normalize distribution; the remaining data were not trans-
formed due to their normal distribution [52]. Since multiple
comparisons were performed between the 4 experimental
conditions within the same time of treatment, transformed
or nontransformed data were subjected to the least signiﬁ-
cant diﬀerence (LSD) test. The common variance was esti-
mated from a one-way unbalanced analysis of variance
(ANOVA) within the same time of treatment, and no sig-
niﬁcant diﬀerences were declared unless ANOVA was signif-
icant [53]. Changes in proportions of eosinophils within the
diﬀerent histological layers of the uterus were evaluated by
the χ2 test.
3. Results
3.1. Blood Lead Levels. Lead levels in adult pregnant rats
nonexposed to lead displayed values under 2μg/dL while
pregnant rats 1 to 7 days after lead exposure displayed
35.1μg/dL; no diﬀerences were detected within the 7 days
following exposure. The oﬀspring of lead-exposed mothers
displayed 20.6μg/dL at the time of blood and uterus sample
collection while oﬀspring of nonexposed control mothers
displayed 4.4μg/dL.
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Figure 1: Comparison of the eﬀects of prenatal exposure to
lead and chronic exposure to lead on estrogen-induced uterine
eosinophilia measured in the endometrium. Prenatally exposed rats
were subjected to s.c. injection of their pregnant mothers with a
lead acetate (P) or saline physiological solution at their 14th day of
pregnancy.Frombirthon,thepupswerebreastfedbytheirmothers.
Attheageof21daystheanimalsweretreatedwithestradiol-17β (E)
or vehicle (V). The uteri were obtained 6h after hormone or vehicle
administration. Previously reported data from chronically exposed
rats are shown for comparison purposes (see [14]). Bars indicate
means(expressedaspercentageofmaximalresponsetoestradiol) ±
standard error of the mean. Statistics: LSD test. ∗∗ or ++, P<0.01;
∗∗∗ or +++, P<0.001; ∗, comparisons to the homologous condition
without estrogen; +, comparisons to the homologous condition
without lead.
3.2. Hematologic Parameters. No eﬀects of prenatal lead
exposure were detected in the total number of leukocytes,
eosinophils, lymphocytes, monocytes, or neutrophils per μL
blood in the oﬀspring at the age of 21 or 22 days. Similarly,
no changes in blood eosinophil degranulation were detected
under the eﬀect of prenatal exposure to lead (data not
shown).Estrogentreatmentofeitherexposedornonexposed
oﬀspring did not induce any changes in these parameters.
3.3. Uterine Eosinophilia. Prenatal exposure to lead strongly
enhanced estrogen-induced increase in endometrial eosino-
p h i l sa t6ho fh o r m o n et r e a t m e n t( Figure 1). This response
to estrogen diﬀered from previously reported [14]d e c r e a s e
in endometrial eosinophils in animals under chronic expo-
sure to lead (Figure 1). No signiﬁcant change was detected in
mesometrial eosinophils of estrogen-treated rats under the
eﬀect of prenatal exposure to lead (data not shown). Prenatal
exposure to lead decreased the proportion of eosinophils
located in the mesometrium at 6h of hormone stimulation
(from 36.8% to 20.1%; P<0.001, χ2 test). This response
to estrogen in prenatally exposed animals was diﬀerent
from previously reported [14] increase in the proportion
of eosinophils located in the mesometrium (from 38.1% to
51,9%; P<0.01, χ2 test) in animals under chronic lead
exposure.
3.4. Endometrial Edema. Prenatal exposure to lead strongly
enhanced estrogen-induced edema in deep endometrial4 ISRN Obstetrics and Gynecology
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Figure 2: Comparison of the eﬀects of prenatal exposure to
lead and chronic exposure to lead on estrogen-induced edema
in deep endometrial stroma, measured as increases in reciprocal
value of cell density. Prenatally exposed rats were subjected to s.c.
injection of their pregnant mothers with a lead acetate (P) or saline
physiological solution at their 14th day of pregnancy. From birth
on, the pups were breastfed by their mothers. At the age of 21 days
the animals were treated with estradiol-17β (E) or vehicle (V). The
uteri were obtained 6h after hormone or vehicle administration.
Previously reported data from chronically exposed rats are shown
for comparison purposes (see [14]). Bars indicate means (expressed
as percentage of maximal response to estradiol) ± standard error of
the mean. Statistics: LSD test. ∗, P<0.05; ∗∗, P<0.01; ∗∗∗ or +++,
P<0.001; ∗, comparisons to the homologous condition without
estrogen; +, comparisons to the homologous condition without
lead.
stroma (Figure 2) at 6h of hormone stimulation. This re-
sponse diﬀers from previously reported [14] inhibition of
estrogen-induced endometrial edema following chronic ex-
posure to lead (Figure 2).
3.5. Luminal Epithelial Hypertrophy. Prenatal exposure to
lead strongly enhanced estrogen-induced increase in lumi-
nal epithelial cell volume 24h after hormone stimulation
(Figure 3). A previous report [14] shows a similar enhance-
ment of estrogen-induced luminal epithelial hypertrophy
under the eﬀect of chronic exposure to lead (for comparison
shown in Figure 3).
3.6.HypertrophyinCircularMyometrium. Leadexposuredid
not signiﬁcantly modify estrogen-induced cell hypertrophy
in this histological layer, 24h after hormone stimulation
(Figure 4). It was previously reported [14] that chronic
exposure to lead neither signiﬁcantly modiﬁes this response
to estrogen (for comparison shown in Figure 4).
4. Discussion
The present study provides evidence that prenatal exposure
to lead enhances estrogen-induced uterine eosinophilia
6h after hormone treatment, mainly in the endometrium
while estrogen-induced increase in eosinophils in the me-
sometrium is not signiﬁcantly aﬀected. The ﬁnding of
a decreased proportion of eosinophils located in the
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Figure 3: Comparison of the eﬀects of prenatal exposure to lead
and chronic exposure to lead on estrogen-induced hypertrophy
of luminal epithelial cells, measured as increase in their cellular
volume. Prenatally exposed rats were subjected to s.c. injection
of their pregnant mothers with a lead acetate (P) or saline
physiological solution at their 14th day of pregnancy. From birth
on, the pups were breastfed by their mothers. At the age of 21 days
the animals were treated with estradiol-17β (E) or vehicle (V). The
uteri were obtained 24h after hormone or vehicle administration.
Previously reported data from chronically exposed rats are shown
for comparison purposes (see [14]). Bars indicate means (expressed
as percentage of maximal response to estradiol) ± standard error of
the mean. Statistics: LSD test. ∗∗, P<0.01; ∗∗∗ or +++, P<0.001;
∗, comparisons to the homologous condition without estrogen; +,
comparisons to the homologous condition without lead.
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Figure 4: Comparison of the eﬀects of prenatal exposure to lead
and chronic exposure to lead on estrogen-induced myometrial
hypertrophy, measured as increase in cell volume of circular
myometrium. Prenatally exposed rats were subjected to s.c. injec-
tion of their pregnant mothers with a lead acetate (P) or saline
physiological solution at their 14th day of pregnancy. From birth
on, the pups were breastfed by their mothers. At the age of 21 days
the animals were treated with estradiol-17β (E) or vehicle (V). The
uteri were obtained 24h after hormone or vehicle administration.
Previously reported data from chronically exposed rats are shown
for comparison purposes (see [14]). Bars indicate means (expressed
as percentage of maximal response to estradiol) ± standard error
of the mean. Statistics: LSD test. ∗∗, P<0.01; ∗∗∗P<0.001; ∗,
comparisons to the homologous condition without estrogen.
mesometrium in prenatally exposed animals suggests in-
creased eosinophil migration from mesometrium towards
myoetrium and endometrium. This agrees with the increaseISRN Obstetrics and Gynecology 5
in estrogen-induced edema in endometrial stroma in pre-
natally exposed animals, since endometrial edema is medi-
ated by enzymes released from eosinophils migrating to this
location; these enzymes depolymerize uterine collagen and
ground substance glycosaminoglycans, increasing extravas-
cular osmotic pressure and uterine vascular permeability
[16, 21].
Several explanations may be suggested for the enhance-
ment of estrogen-induced eosinophil migration towards en-
dometrium in prenatally exposed rats. Eosinophils may have
increased intrinsic ability for migration through connective
tissue, they may contain an increased amount of enzymes
needed to increase ground substance ﬂuidity, or display
increased sensitivity to chemotactic agents; the secretion of
a putative eosinophil chemotactic substance by endometrial
tissue[54]maybeincreasedaswell.Thesealterationsmaybe
mediated by qualitative or quantitative changes in estrogen
receptors, described to occur following prenatal exposure
to lead [48], or by alterations in regulatory mechanisms.
The latter may occur in the aﬀected uterine cell types and
include proteins such as heat shock proteins, for instance
hsp90, which is known to interact with estrogen receptors
and modify their activity [55], or hsp70, which also bind
estrogen receptors and may protect them against a number
of adverse conditions [56, 57]. It may also involve systemic
endocrine changes, such as glucocorticoids, catecholamines,
prolactin or growth hormone [18], which are known to
modifyresponsestoestrogen[16,17];thesepossibilitiesneed
to be further investigated.
The present report describes an important enhancement
of estrogen-induced uterine luminal epithelium hypertrophy
under the eﬀect of prenatal exposure to lead. It is similar to
that reported following acute [13], subacute [12], or chronic
[14] exposure to lead. In contraposition to ﬁndings in the
uterine luminal epithelium, prenatal exposure did not cause
a signiﬁcant change in estrogen-induced hypertrophy in
circular myometrium, an eﬀect that was not found following
chronic exposure either [14]. The diﬀerence between both
cell types may be explained by the accumulation of lead in
luminal epithelium [58], or to diﬀerences in sensitivity of
these cell-types to lead exposure. This ﬁnding conﬁrms our
previous suggestions that toxic substances may interact in a
diﬀerentwaywiththediﬀerentuterinecell-types[12–14,16],
and points to the need for the consideration of all cell types
in every study of toxicity in reproductive organs.
With regard to hematologic parameters reported to be
aﬀected following subacute [59] or chronic [26]e x p o s u r et o
lead (increase in the degranulation of blood eosinophils and
increase in total leukocyte counts, eosinophils, lymphocytes,
monocytes, and neutrophils in the blood), prenatal exposure
to lead did not revealed any delayed eﬀects on them.
Taking into consideration the role of eosinophils in estrogen
action in the uterus, the lack of eﬀect of exposure on
these leukocytes may explain in part diﬀerences in responses
to estrogen in the uterus following the diﬀerent times of
exposure to lead.
It is striking that three responses to estrogen stimula-
tion (estrogen-induced endometrial eosinophilia, eosinophil
migration from mesometrium towards myometrium and
endometrium, and endometrial edema), but not the remain-
ing responses (luminal epithelial and myometrial cell hyper-
trophy), display just the opposite behavior when comparing
prenatal exposure and chronic exposure. Estrogen-induced
increase in eosinophils in the endometrium appears to be
enhanced in prenatally exposed rats while it is inhibited
following chronic exposure. Eosinophil migration from
mesometrium towards myometrium and endometrium is
enhanced in prenatally exposed animals while it is inhibited
in chronically exposed rats. Estrogen-induced endometrial
edema is enhanced in prenatally exposed rats while the
response is inhibited following chronic exposure. The dif-
ferences appears even more conspicuously, considering that
lead blood levels in prenatally exposed rats at the age
of estrogen stimulation are much higher than those in
nonexposed controls, although lower than following chronic
exposure, that is, mimicking a less severe chronic exposure.
Since it was reasonable to expect, in prenatally exposed
rats, an inhibition of endometrial eosinophilia and edema
of a smaller magnitude than in prenatally exposed rats, our
ﬁnding of enhancement of the responses to estrogen in pre-
natally exposed animals was completely unexpected. Our
ﬁnding suggests that prenatal exposure may antagonize the
eﬀects of chronic exposure to lead in endometrial eosin-
ophilia and edema, thus providing a partial protection of cell
function against adverse eﬀects of chronic exposure to lead.
We have previously proposed that estrogen-induced
endometrial edema and destruction of endometrial extracel-
lular matrix by plasmin formed by eosinophil plasminogen
activators are required to facilitate blastocyst implantation
[16]. Eosinophils were also proposed to suppress some
immune reaction sequelae that could aﬀect the development
oftheproductofconception[16].Therefore,iftheinhibition
of estrogen-induced endometrial eosinophilia and edema
under chronic exposure to lead contribute to the infertile
condition, prenatalexposure may neutralize these eﬀectsand
provide a partial protection against these adverse eﬀects of
chronic exposure.
Nevertheless, at this point, it is not possible to ascertain
whether the remaining eﬀects of prenatal exposure to lead
in the uterus may interfere with blastocyst implantation and
its development in the uterus. Further work is needed to
evaluate this possibility as well as eﬀects in other organs of
the reproductive system.
Imprinting can be considered a general biological epige-
netic mechanism. It causes changes in the diﬀerentiation or
programming in various cell-types under the eﬀect of peri-
natal exposure to various agents or conditions; these changes
persistthroughlifeandcanbedetectedthroughbiochemical,
morphological, and functional changes in aﬀected cells. We
now propose that this process may have persisted through
evolution as a non-genetic adaptive mechanism to provide
protection against long-term environmental variations that
otherwise may cause the extinction of species not displaying
this kind of adaptation. In the particular case of lead, it may
protect several reproductive functions and their mechanisms
against damage by this pollutant, allowing oﬀspring of
prenatally or perinatally exposed individuals to survive and
further reproduce in a newly polluted environment.6 ISRN Obstetrics and Gynecology
Leadisalsoknowntoaﬀectotherorgansandsystems.For
instance, it causes neurological and neurobehavioral changes
that were reported in countries with high lead pollution
levels [60–63]. Among these changes, it impairs learning
in experimental animals [64] and in humans [63, 65], and
development of aggressive and delinquent behavior [66]
that evolved in correlation with lead blood levels during
p r e s c h o o la g e si nd i ﬀerent countries [67] .S t u d i e si nr a t sh a d
shown thatchronic exposure to lead in rats induces astroglial
changes in the brain and reduces dopaminergic neurons in
the substantia nigra [68], increases brain serotonin as well
as immunoreactive serotoninergic cell bodies density in the
dorsal raphe nucleus, and increases in anxiety [69]. Prenatal
exposuretolead,inturn,aﬀectedinthepostnatalage,energy
status of neuronal mitochondria, and altered neuronal func-
tioninsuchawaythatcouldplayaroleinneurodegeneration
[70]. No studies were reported comparing the eﬀects of
chronic exposure and of prenatal exposure on the same
neurologic and neurobehavior parameters. These studies are
necessary to ascertain whether there is an antagonism of
prenatal exposure on chronic exposure eﬀects in a similar
way as described for the uterus in the present report.
5. Conclusion
We conclude from this study that prenatal exposure to lead
causes persistent changes in several responses to estrogen
in the rat uterus, detected at postnatal age of 21 days,
and suggest that prenatal exposure may constitute a non-
genetic adaptive mechanism to antagonize some of the
adverse eﬀects of chronic exposure to lead in the uterus,
thusprotectingitagainstreproductiveimpairmentcausedby
chronic exposure to lead.
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